Delivery Order SPE2DB22D1017-SPE2DB25FF5PQ
Award Date
2/14/25
Potential Completion Date
2/18/25
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ACTEMRA 162 MG/0.9 ML syringes, with a ceiling value of $8,264.87 and a period of performance through January 13, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty pharmaceutical product. The contract has a ceiling value of $5,755.68 and a completion date of February 12, 2025. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $1,973.16, is for the delivery of ACTEMRA 162 MG/0.9 ML syringes to support military treatment programs and facilities. The contract has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,792.62 firm-fixed-price delivery order is for the supply of Actemra 162 mg/0.9 ml syringes, a specialty medication. The contract has an ultimate completion date of September 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,301.77, is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of October 20, 2023. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,721.76 firm fixed price contract is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty medication, with a completion date of November 29, 2024. The award is not associated with a set-aside program, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4558082403 - ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML. The $16,633.92 firm-fixed-price contract has an ultimate completion date of August 15, 2022 and was awarded on August 12, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ACTEMRA 162 MG/0.9 ML syringes. The contract is a Delivery Order with a Firm Fixed Price type and has a ceiling value of $7,442.12. The contract does not have a set-aside designation, and the ultimate completion date is September 5, 2024. Amerisourcebergen is the prime contractor for this award, which is part of a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,530.58, is for the supply of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty medication. The contract is a firm fixed-price delivery order with a completion date of January 16, 2025. There is no set-aside designation on this contract. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,964.39 firm-fixed-price delivery order is for the supply of ACTEMRA 162 MG/0.9 ML syringes, with a completion date of October 25, 2024. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of...